Literature DB >> 16514156

Genetic diversity of the C protein beta-antigen gene and its upstream regions within clonally related groups of type Ia and Ib group B streptococci.

Noriyuki Nagano1,2, Yukiko Nagano2, Ryuichi Nakano1, Ryoichi Okamoto1, Matsuhisa Inoue1.   

Abstract

C protein beta antigen (Bac), a surface protein of group B streptococci (GBS), is known to concurrently bind the Fc portion of IgA and factor H (FH). The authors' previous work has demonstrated that mRNA expression levels show diversity among clonally related strains containing genes (bac) encoding Bac, with high expression noted in invasive strains. In this study, the bac gene and upstream regions containing putative promoters, three ORFs and an IS1381 insertion sequence were characterized. Three invasive strains showed high bac expression levels and did not show any notable mutations except one strain producing Bac that was able to bind FH but not IgA. A deletion of 51 amino acid residues, including part of the Bac IgA-binding region, was identified and hypothesized to contribute to the loss of the IgA-binding ability of this strain. A vaginal strain that showed somewhat higher bac expression levels and produced Bac lacking immunoreactivity contained an 11 bp deletion, which generated a premature termination codon, in the region preceding the IgA-binding region. In another vaginal strain that did not express bac, disruption of the upstream ORFs of the sensor histidine kinase and DNA-binding response regulator, due to frameshift mutations, was noted although it is not known whether these proteins directly affect bac expression levels. An IS1381 insertion into the promoter region was found in another vaginal strain that showed low expression levels and produced Bac with a significantly larger proline-rich repeat region. These results demonstrate considerable genetic diversity of the bac and upstream regions of invasive and noninvasive GBS, which may contribute to the variability of bac expression levels among those strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514156     DOI: 10.1099/mic.0.28535-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

2.  Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis.

Authors:  Yaya Pian; Shuzhen Gan; Shujie Wang; Jie Guo; Pingping Wang; Yuling Zheng; Xuehui Cai; Yongqiang Jiang; Yuan Yuan
Journal:  Infect Immun       Date:  2012-04-23       Impact factor: 3.441

3.  Inactivation of DNA-binding response regulator Sak189 abrogates beta-antigen expression and affects virulence of Streptococcus agalactiae.

Authors:  Anastasia S Rozhdestvenskaya; Artem A Totolian; Alexander V Dmitriev
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

4.  Heterogeneity of hemolysin expression during neonatal Streptococcus agalactiae sepsis.

Authors:  Anja Sigge; Manuel Schmid; Stefanie Mauerer; Barbara Spellerberg
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

5.  Natural Mutations in Streptococcus agalactiae Resulting in Abrogation of β Antigen Production.

Authors:  Anastasia Vasilyeva; Ilda Santos Sanches; Carlos Florindo; Alexander Dmitriev
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

6.  Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.

Authors:  Nina M van Sorge; Daniel A Bonsor; Liwen Deng; Erik Lindahl; Verena Schmitt; Mykola Lyndin; Alexej Schmidt; Olof R Nilsson; Jaime Brizuela; Elena Boero; Eric J Sundberg; Jos A G van Strijp; Kelly S Doran; Bernhard B Singer; Gunnar Lindahl; Alex J McCarthy
Journal:  EMBO J       Date:  2021-02-01       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.